AXT and CELLINK Form a Formidable Australian Bioprinting Partnership

FHS
July 25, 2023
5:46 am

3D bioprinting is experiencing rapid growth as the technology continues to evolve. This is certainly the case in Australia and AXT, who are already well entrenched in the field are pleased to announce that they are strengthening their position by partnering with CELLINK.

Adicet pauses preclinical programme in CAR-T cell pipeline reprioritisation – Pharmaceutical Technology

Adicet plans to file an investigational new drug (IND) for ADI-270 with the FDA in H1 2024. Image Credit: ART-ur / Shutterstock. Adicet Bio plans

November 9, 2023

Multiple subtypes of major depressive disorder identified using brain imaging

Major depressive disorder (MDD) is not only among the most common mental illnesses, affecting over 8% of Americans, but it is also extremely variable from

June 27, 2023

Radiometer and Etiometry announce commercial partnership to empower physicians by optimizing workflows and decision making in high acuity care settings

Radiometer, a leading medical device company specializing in acute care testing solutions, and Etiometry, a leader in clinical decision-support software for critical care, today announced

July 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.